One in three men will experience moderate to severe lower urinary tract symptoms in their lifetime, with symptoms including ...
Teleflex Incorporated announced the presentation of multiple clinical studies at the 2025 American Urological Association Annual Meeting in Las Vegas, highlighting advancements in treatments for ...
These can all be symptoms of benign prostatic hyperplasia (BPH), also known as an enlarged prostate. While BPH is common as ...
Prostate enlargement is a common age-related condition affecting millions of men. Learn about its symptoms, risk factors, ...
An enlarged prostate is very common – affecting more than 42 million men in the US alone. And while there are different ...
BPH prostate treatment market is evolving toward a more patient-focused, technology-driven ecosystem. As innovation in both pharmaceuticals and minimally invasive procedures accelerates, companies ...
AngioDynamics' FDA IDE approval for RELIEF advances NanoKnife IRE study as a potential minimally invasive BPH treatment.
A urologist at the Fox Chase-Temple Urologic Institute explains the options and warns that ignoring an enlarged prostate ...
These new findings are important as α-blockers (ABs) are the most prescribed class of medications for patients with benign prostatic hyperplasia (BPH), but the cardiovascular safety profile of this ...
The US Food and Drug Administration has approved a new catheter designed to treat urinary tract symptoms of an enlarged prostate, also known as benign prostate hyperplasia (BPH). Designed and marketed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results